Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Transplantation | 5 | 2023 | 558 | 1.120 |
Why?
|
| Ureaplasma Infections | 1 | 2023 | 9 | 0.790 |
Why?
|
| Agammaglobulinemia | 1 | 2023 | 43 | 0.770 |
Why?
|
| Bone Marrow Transplantation | 1 | 2025 | 590 | 0.760 |
Why?
|
| Arthritis | 1 | 2023 | 83 | 0.750 |
Why?
|
| Acute Kidney Injury | 3 | 2025 | 698 | 0.680 |
Why?
|
| Diabetes Mellitus, Type 1 | 4 | 2009 | 877 | 0.490 |
Why?
|
| Diabetic Nephropathies | 2 | 2008 | 115 | 0.460 |
Why?
|
| Anti-Bacterial Agents | 1 | 2025 | 2569 | 0.400 |
Why?
|
| Albuminuria | 3 | 2009 | 105 | 0.360 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 2 | 2023 | 34 | 0.310 |
Why?
|
| Creatinine | 3 | 2025 | 396 | 0.250 |
Why?
|
| Aminoglycosides | 1 | 2025 | 44 | 0.230 |
Why?
|
| Kidney Diseases | 1 | 2009 | 471 | 0.220 |
Why?
|
| Vancomycin | 1 | 2025 | 220 | 0.200 |
Why?
|
| Ureaplasma | 1 | 2023 | 8 | 0.200 |
Why?
|
| Kidney | 2 | 2008 | 1278 | 0.190 |
Why?
|
| Adolescent | 8 | 2025 | 20725 | 0.180 |
Why?
|
| Rituximab | 1 | 2023 | 171 | 0.180 |
Why?
|
| Aquaporin 2 | 1 | 2021 | 5 | 0.170 |
Why?
|
| Diabetes Insipidus, Nephrogenic | 1 | 2021 | 2 | 0.170 |
Why?
|
| Hospitals, Pediatric | 1 | 2025 | 797 | 0.160 |
Why?
|
| Transplant Recipients | 1 | 2022 | 228 | 0.160 |
Why?
|
| Child, Hospitalized | 1 | 2019 | 77 | 0.150 |
Why?
|
| Child | 7 | 2025 | 26094 | 0.140 |
Why?
|
| Graft Rejection | 1 | 2022 | 555 | 0.140 |
Why?
|
| Disease Progression | 3 | 2009 | 2194 | 0.130 |
Why?
|
| Actinin | 1 | 2016 | 7 | 0.130 |
Why?
|
| Humans | 15 | 2025 | 130436 | 0.120 |
Why?
|
| Infant | 5 | 2025 | 13228 | 0.110 |
Why?
|
| Glomerular Filtration Rate | 3 | 2008 | 568 | 0.110 |
Why?
|
| Renin-Angiotensin System | 1 | 2015 | 104 | 0.110 |
Why?
|
| Maternal Exposure | 1 | 2015 | 149 | 0.100 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 214 | 0.100 |
Why?
|
| Nephrology | 1 | 2015 | 159 | 0.100 |
Why?
|
| Child, Preschool | 3 | 2025 | 14943 | 0.090 |
Why?
|
| Female | 8 | 2025 | 70351 | 0.090 |
Why?
|
| Fetus | 1 | 2015 | 567 | 0.090 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2015 | 363 | 0.090 |
Why?
|
| Retrospective Studies | 4 | 2025 | 17510 | 0.090 |
Why?
|
| Urate Oxidase | 1 | 2009 | 16 | 0.080 |
Why?
|
| United States | 1 | 2025 | 11874 | 0.080 |
Why?
|
| Hyperuricemia | 1 | 2009 | 39 | 0.070 |
Why?
|
| Gout Suppressants | 1 | 2009 | 75 | 0.070 |
Why?
|
| Serum Albumin | 1 | 2008 | 101 | 0.070 |
Why?
|
| Reference Values | 2 | 2008 | 675 | 0.070 |
Why?
|
| Cysteamine | 1 | 2007 | 15 | 0.070 |
Why?
|
| Male | 6 | 2025 | 64471 | 0.070 |
Why?
|
| Radiation-Protective Agents | 1 | 2007 | 19 | 0.070 |
Why?
|
| Cystinosis | 1 | 2007 | 15 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 1317 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2015 | 845 | 0.060 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2007 | 148 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2023 | 5034 | 0.050 |
Why?
|
| Biopsy | 1 | 2008 | 1244 | 0.050 |
Why?
|
| Age of Onset | 1 | 2005 | 595 | 0.050 |
Why?
|
| Apolipoprotein L1 | 1 | 2023 | 13 | 0.050 |
Why?
|
| Insulin Resistance | 1 | 2008 | 687 | 0.050 |
Why?
|
| Apolipoproteins | 1 | 2023 | 69 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 5153 | 0.040 |
Why?
|
| Xenopus laevis | 1 | 2021 | 112 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2005 | 1342 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2021 | 1016 | 0.040 |
Why?
|
| Oocytes | 1 | 2021 | 282 | 0.040 |
Why?
|
| Prognosis | 1 | 2008 | 4861 | 0.040 |
Why?
|
| Biomarkers | 1 | 2008 | 3385 | 0.040 |
Why?
|
| Pedigree | 1 | 2021 | 1673 | 0.030 |
Why?
|
| Genotype | 1 | 2023 | 2589 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 413 | 0.030 |
Why?
|
| Midwestern United States | 1 | 2015 | 16 | 0.030 |
Why?
|
| Mutation | 2 | 2021 | 6098 | 0.030 |
Why?
|
| Young Adult | 1 | 2009 | 9993 | 0.030 |
Why?
|
| Time Factors | 1 | 2005 | 6200 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2008 | 2099 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2015 | 122 | 0.030 |
Why?
|
| Adult | 2 | 2021 | 31120 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2015 | 161 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2019 | 707 | 0.020 |
Why?
|
| Graft Survival | 1 | 2015 | 459 | 0.020 |
Why?
|
| Risk Factors | 2 | 2023 | 10948 | 0.020 |
Why?
|
| Blood Urea Nitrogen | 1 | 2009 | 69 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2016 | 1107 | 0.020 |
Why?
|
| Urination | 1 | 2009 | 23 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2015 | 8519 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2019 | 6424 | 0.020 |
Why?
|
| Minnesota | 1 | 2008 | 180 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 2015 | 949 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2007 | 236 | 0.020 |
Why?
|
| Gastrointestinal Motility | 1 | 2007 | 61 | 0.020 |
Why?
|
| Fasting | 1 | 2008 | 304 | 0.020 |
Why?
|
| Hypothyroidism | 1 | 2007 | 76 | 0.020 |
Why?
|
| Gestational Age | 1 | 2009 | 1208 | 0.010 |
Why?
|
| Renal Insufficiency | 1 | 2007 | 257 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 1167 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2007 | 1216 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2008 | 1485 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 2007 | 337 | 0.010 |
Why?
|
| Insulin | 1 | 2008 | 1140 | 0.010 |
Why?
|
| Pregnancy | 1 | 2015 | 7394 | 0.010 |
Why?
|
| Animals | 1 | 2021 | 33857 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2009 | 12834 | 0.010 |
Why?
|